Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Endocyte Inc (NQ: ECYT)
23.99 USD  UNCHANGED
Last Price  /  Updated: 7:31 PM EST, Dec 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 23.99
Bid (Size) 23.99 (3)
Ask (Size) 24.00 (400)
Prev. Close 23.99
Today's Range 23.99 - 23.99
52wk Range N/A - N/A
Shares Outstanding 69,501,640
Dividend Yield N/A
Performance
Top News
More News
Endocyte Stockholders Approve Merger Agreement with Novartis AG
Endocyte, Inc. (Nasdaq:ECYT) (“Endocyte”), a biopharmaceutical company developing targeted therapeutics for cancer treatment, today announced that at its Special Meeting of Stockholders held earlier... Read More
from GlobeNewswire News Releases
Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Endocyte, Inc. In The U.S. District Court For The Southern District Of New York
Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Southern District of New York, Case No. 1:18-cv-10392-JMF, on behalf... Read More
from PR Newswire
More News
Read More
Recent Analysis Shows Audentes Therapeutics, Endocyte, Bluerock Residential Growth REIT, Air Products and Chemicals, BWX Technologies, and Modine Manufacturing Market Influences — Renewed Outlook, Key
from GlobeNewswire News Releases
Endocyte Provides Third Quarter 2018 Financial Results and Operational Update
from GlobeNewswire News Releases
2.4% Return Seen to Date on SmarTrend Endocyte Inc Call (ECYT)
from Comtex SmarTrend® News Briefs
Endocyte Inc Shares Up 2.4% Since SmarTrend's Buy Recommendation (ECYT)
from Comtex SmarTrend® News Briefs
Uptrend Call Working As Endocyte Inc Stock Rises 2.4% (ECYT)
from Comtex SmarTrend® News Briefs
Uptrend Call Working As Endocyte Inc Stock Rises 2.4% (ECYT)
from Comtex SmarTrend® News Briefs
Endocyte Inc Has Returned 2.4% Since SmarTrend Recommendation (ECYT)
from Comtex SmarTrend® News Briefs
Endocyte Inc Has Returned 2.4% Since SmarTrend Recommendation (ECYT)
from Comtex SmarTrend® News Briefs
Endocyte Inc Shares Up 2.4% Since SmarTrend's Buy Recommendation (ECYT)
from Comtex SmarTrend® News Briefs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.